| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population.
|
Carcinogenesis
|
2012
|
1.40
|
|
2
|
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
|
Carcinogenesis
|
2010
|
1.19
|
|
3
|
Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.
|
Genes Chromosomes Cancer
|
2013
|
1.16
|
|
4
|
JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
|
Mol Carcinog
|
2011
|
1.16
|
|
5
|
Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.15
|
|
6
|
Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.
|
Carcinogenesis
|
2010
|
1.11
|
|
7
|
MAP kinase genes and colon and rectal cancer.
|
Carcinogenesis
|
2012
|
1.08
|
|
8
|
Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival.
|
Carcinogenesis
|
2011
|
1.05
|
|
9
|
Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer.
|
Mutat Res
|
2010
|
1.04
|
|
10
|
Genetic variation in bone morphogenetic protein and colon and rectal cancer.
|
Int J Cancer
|
2011
|
0.99
|
|
11
|
Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes.
|
Mutat Res
|
2012
|
0.99
|
|
12
|
VEGFA, FLT1, KDR and colorectal cancer: assessment of disease risk, tumor molecular phenotype, and survival.
|
Mol Carcinog
|
2013
|
0.97
|
|
13
|
Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
|
PLoS One
|
2013
|
0.97
|
|
14
|
Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
|
Breast Cancer Res Treat
|
2013
|
0.93
|
|
15
|
Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.
|
Int J Cancer
|
2013
|
0.92
|
|
16
|
Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study.
|
Int J Mol Epidemiol Genet
|
2012
|
0.91
|
|
17
|
Dietary influence on MAPK-signaling pathways and risk of colon and rectal cancer.
|
Nutr Cancer
|
2013
|
0.89
|
|
18
|
Variation in the CYP19A1 gene and risk of colon and rectal cancer.
|
Cancer Causes Control
|
2011
|
0.89
|
|
19
|
Interleukin genes and associations with colon and rectal cancer risk and overall survival.
|
Int J Cancer
|
2012
|
0.88
|
|
20
|
Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.
|
Cancer
|
2011
|
0.88
|
|
21
|
The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study.
|
Cancer Causes Control
|
2013
|
0.86
|
|
22
|
TERT's role in colorectal carcinogenesis.
|
Mol Carcinog
|
2012
|
0.86
|
|
23
|
Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.
|
PLoS One
|
2012
|
0.86
|
|
24
|
Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer.
|
Dis Colon Rectum
|
2012
|
0.86
|
|
25
|
PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer.
|
Genes Nutr
|
2012
|
0.85
|
|
26
|
Tumor necrosis factor-related genes and colon and rectal cancer.
|
Int J Mol Epidemiol Genet
|
2011
|
0.85
|
|
27
|
SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study.
|
PLoS One
|
2013
|
0.84
|
|
28
|
Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin/NSAIDs: the Breast Cancer Health Disparities Study.
|
Breast Cancer Res Treat
|
2014
|
0.83
|
|
29
|
Lack of correlation between in silico projection of function and quantitative real-time PCR-determined gene expression levels in colon tissue.
|
Pharmgenomics Pers Med
|
2013
|
0.81
|
|
30
|
Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment.
|
Nutr Cancer
|
2011
|
0.80
|
|
31
|
Diet and lifestyle factors interact with MAPK genes to influence survival: the Breast Cancer Health Disparities Study.
|
Cancer Causes Control
|
2014
|
0.78
|
|
32
|
Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: the Breast Cancer Health Disparities Study.
|
Mutat Res
|
2014
|
0.77
|
|
33
|
MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: the Breast Cancer Health Disparities Study.
|
Nutr Cancer
|
2015
|
0.76
|
|
34
|
Energy homeostasis genes and survival after breast cancer diagnosis: the Breast Cancer Health Disparities Study.
|
Cancer Causes Control
|
2016
|
0.76
|